CureMatch
×
  • Physicians
  • BioPharma
  • Employers
  • News
  • Clinical Order
  • About Us
  • Login

CureMatch Partnering with Patient Power to Educate and Empower Cancer Patients and Oncologists

CureMatch Partnering with Patient Power to Educate and Empower Cancer Patients and Oncologists
Press Releases

The goal is to accelerate the adoption of genomics and combination therapy in oncology to increase standard of care for cancer patients

SAN DIEGO, CA – March 30, 2017 – CureMatch, the developer of a decision support system for personalized combination therapy for cancer, and Patient Power, an online news source for cancer patients, today announced a collaborative project designed to empower both patients and oncologists to make the most informed decisions when considering advanced cancer treatments. The goals are to educate patients and their families about cutting-edge treatment options and to support oncologists with actionable knowledge and insight so that they can more easily select available personalized therapies for their patients.

Patient Power is devoted to providing knowledge to cancer patients and their families so that they can get the best possible treatment and return to or maintain good health.  The Patient Power site welcomes more than 60,000 monthly visits. Patients and their “circle of support” learn from leading medical experts, researchers, advocates, and other patients about their disease; they can attend in person and online events and forums; and can subscribe to receive regular updates on new findings and treatments.

CureMatch is the only company to offer a report that guides oncologists in the selection of personalized combination therapies, using supercomputing and the latest discoveries in genomics and proteomics. CureMatch analyzes more than 4.5 million different drug combinations to find and rank the most advanced cancer treatments, customized specifically for the individual patient. The technology was originally developed at the UCSD Moores Cancer Center and San Diego Supercomputer Center to guide clinical decision-making when discussing potential therapy options for patients with complex cases.

The new collaboration will enable the joint team to develop content targeting patients who are interested in topics such as next-generation sequencing and personalized combination therapy. This material will be used to better educate patients and their families about options that are on the leading edge of cancer treatment.

“In our experience, patients and caregivers are the biggest advocates for personalized medicine,” said Blaise Barrelet, CEO and Co-Founder of CureMatch. “However, the vast majority are not aware that these options exist. Patient Power knows exactly how to reach patients and caregivers and provide content for them in a way that is effective and actionable.”

The first content released was a web interview with Patient Power Host Andrew Schorr, a two-time cancer survivor, and Dr. Razelle Kurzrock, CureMatch Co-Founder and Chief Medical Advisor, and Director of the Center for Personalized Cancer Therapy at UC San Diego. In the interview, Dr. Kurzrock describes the limitations of cancer care, how supercomputing and genomics are used to treat cancer today, and what patients can do to understand the complex data.

The collaboration is also focused on helping oncologists make more informed decisions when considering advanced treatment options. Today, only about 2% of cancer patients have their tumors profiled using techniques such as next-generation sequencing, and only a fraction of those patients is given cancer treatments that actually make use of this data. The slow adoption of personalized medicine is largely due to the information burden that has been placed on oncologists. This burden is the result of the explosion of new sources of data, new and experimental cancer drugs, and new discoveries in fields such as immunotherapy and targeted therapy.

The approach taken by CureMatch and Patient Power is to reach out to oncologists – and patients – and show them how decision support can be used to provide actionable knowledge and insight rather than simply providing more information. Access to knowledge and insight enables oncologists to make rapid, informed decisions, and is the key to the adoption of personalized medicine in oncology.

“The science of cancer treatment is moving so rapidly that most oncologists – and certainly their patients – can’t keep up,” said Esther Schorr, Chief Operating Officer/Co-Founder of Patient Power. ”There is exponential growth in the scientific understanding of how genetics plays a role in cancer, which is great.  However, at the same time, matching an individual’s genetic profile with the right treatment plan is growing in complexity…this is where decision support tools like CureMatch, along with education of patients about their options, becomes even more critical.”

 

About CureMatch

CureMatch™, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized for individual patients based on their molecular tumor profile. CureMatch enables oncologists to become experts in personalized medicine by providing them with actionable intelligence towards advanced cancer treatment options. For more information visit www.curematch.com.

Media Contact

Martin Culjat, PhD.
(858)859-2873
press@curematch.com

Share

  • LinkedIn
  • Facebook
  • Twitter
  • Reddit
  • Email
  • Print

Receive CureMatch News

Sign up for personalized oncology information and resources.
* = required field

Recent News & Resources

  • Launch of CureMatch Certified Precision Oncology Recognition Award

    CureMatch, a leader in precision oncology, is proud to announce the establishment of the CureMatch...

  • CureMatch Announces Collaboration with Mark Cuban Cost Plus Drug Company to Promote Affordable Cancer Treatment

    CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to...

  • CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments

    CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision...

  • The Complex Cancer Puzzle | Video 1

    ShareLinkedInFacebookTwitterRedditEmailPrint

  • CureMatch and Mprobe Partner to Help Cancer Patients Determine Optimal Treatments

    CureMatch will leverage mProbe’s targeted proteomics platform to assess individual proteins within patients’ tumor tissues....

  • CureMatch Granted CPT® Code by American Medical Association for its Algorithmic Cancer Therapy Ranking Service

    Oncologists will be able to submit claims to payers using a Category III CPT code,...

  • CureMatch CEO Navid Alipour named a Top 50 Honoree Leader of Influence in Life Science by San Diego Business Journal

    Congratulations to CureMatch CEO Navid Alipour for being named a Top Leader of Influence in...

Validation

  • Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

    Malignancies are molecularly complex and become more resistant with each line of...

  • Significance of Scores Generated by a Cancer Therapy Matching Engine for Patient Outcomes

    Oncologists need effective precision medicine tools to navigate the myriad of therapeutic...

  • Real-world Data from a Molecular Tumor Board Demonstrates Improved Outcomes with a Precision N-of-One Strategy

    Next-generation sequencing (NGS) has allowed the identification of novel potential targets for...

  • The Crossroads of Precision Medicine and Therapeutic Decision-Making: Use of an Analytical Computational Platform to Predict Response to Cancer Treatments

    Oncology is currently the largest area of clinical health expenditures for prescription...

Archives

  • May 2024 (1)
  • October 2023 (1)
  • June 2023 (1)
  • May 2023 (1)
  • March 2023 (1)
  • January 2023 (1)
  • July 2022 (2)
  • June 2022 (2)
  • April 2022 (1)
  • March 2022 (1)
  • February 2022 (3)
  • November 2021 (1)
  • October 2021 (2)
  • August 2021 (2)
  • July 2021 (1)
  • June 2021 (4)
  • May 2021 (1)
  • April 2021 (2)
  • March 2021 (1)
  • December 2020 (2)
  • October 2020 (3)
  • April 2020 (1)
  • November 2019 (2)
  • September 2019 (1)
  • August 2019 (1)
  • July 2019 (2)
  • April 2019 (1)
  • March 2019 (2)
  • September 2018 (1)
  • August 2018 (1)
  • July 2018 (1)
  • June 2018 (5)
  • May 2018 (1)
  • April 2018 (4)
  • March 2018 (1)
  • February 2018 (3)
  • January 2018 (4)
  • December 2017 (3)
  • November 2017 (1)
  • October 2017 (1)
  • September 2017 (3)
  • August 2017 (4)
  • June 2017 (6)
  • May 2017 (9)
  • April 2017 (11)
  • March 2017 (8)
  • February 2017 (3)
  • January 2017 (5)
  • October 2016 (1)
  • September 2016 (5)
  • August 2016 (2)
  • May 2016 (1)
  • April 2016 (1)

logo

+1 (858) 215-1313

Quick Links

  • Home
  • Physicians
  • About CureMatch
  • News and Latest Posts
  • Contact Us
  • FAQ

Latest News and Results

  • Launch of CureMatch Certified Precision Oncology Recognition Award May 8

    CureMatch, a leader in precision oncology, is proud to announce the establishment of the CureMatch...

  • CureMatch Announces Collaboration with Mark Cuban Cost Plus Drug Company to Promote Affordable Cancer Treatment Oct 7

    CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to...

  • CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments Jun 28

    CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision...

© 2025 CureMatch, Inc. CureMatch is a registered trademark.
Terms of Use | Privacy Policy | HIPAA Notice

Please fill out the information below and a CureMatch representative will reach out to you.

 

Physician Request

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy

Some pages of this website are intended for healthcare professionals

This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.

Otherwise, you will be redirected to the institutional part of this website.

Thank you for your understanding.

I am a healthcare professionalI am not a healthcare professional

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data